U.S. NeuroSurgical Holdings, Inc.

U.S. NeuroSurgical Holdings, Inc.

USNU
U.S. NeuroSurgical Holdings, Inc.US flagOther OTC
1.04
USD
+0.04
- -
22.16MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
0.25
- -
0.33
0.38
0.41
0.44
0.44
0.39
0.41
0.14
- -
- -
- -
- -
Basic EPS, GAAP
0.09
-0.09
0.07
0.05
0.07
0.07
-0.05
0.02
0.07
-0.11
-0.17
-0.09
- -
-0.13
Free Cash Flow per Basic Share
0.11
-0.13
-0.08
0.1
0.24
0.3
0.22
0.2
0.14
0.02
-0.18
-0.1
- -
-0.08
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.13
-0.22
-0.15
-0.1
-0.03
0.04
-0.01
0.01
0.08
-0.04
-0.21
-0.25
- -
-0.27
Tangible Book Value per Share
0.27
0.18
0.25
0.3
0.37
0.44
0.39
0.4
0.47
0.35
0.19
0.07
- -
0.22
Basic Weighted Avg Shares
8
8
8
8
8
8
8
8
8
8
8
9
- -
17
Sales/Revenue/Turnover
2
- -
3
3
3
3
3
3
3
1
- -
- -
- -
- -
Operating Margin (%)
12.63
- -
28.23
18.31
19.12
20.15
23.19
48.53
50.9
-8.29
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
1
-1
1
- -
1
1
- -
- -
1
-1
-1
-1
-2
-2
Effective Tax Rate (%)
33.18
- -
30.14
38.89
38.95
- -
- -
5.96
37.73
- -
- -
- -
- -
- -
Profit Margin (%)
37.27
- -
21.52
13.33
16.69
15.76
-12.3
4.63
16.8
-83.03
- -
- -
- -
- -
Working Capital
2
1
- -
1
1
2
2
1
3
2
1
- -
4
4
LT Debt
- -
3
4
3
3
2
1
- -
- -
- -
- -
- -
- -
- -
Total Equity
2
1
2
2
3
3
3
3
4
3
1
1
4
4
Return on Invested Capital (%)
3.94
- -
8.87
5.09
5.69
- -
- -
28.3
23.67
- -
- -
- -
- -
- -
Return on Capital (%)
79.08
- -
26.04
15.38
19.42
- -
- -
13.07
55.81
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
166.82
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
20
21
Market Capitalization
8
11
14

Working Capital

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
3
4
4
Cash, Cash Equivalents & STI
3
4
4
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
49.31%
87.84%
547.75%
Free Cash Flow
-111.35%
-198.24%
70.03%
Net Income, GAAP
-13.1%
34.94%
151.84%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
-0.05
-0.02
- -
-0.09
2024
-0.03
-0.03
-0.02
- -
- -
2025
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Jeereddi Anjaneya Prasad
Full Time Employees
3
Sector
Healthcare
Industry
Medical - Care Facilities
Address
2400 Research Boulevard Ontario MD United States of America 20850
IPO Date
Oct 9, 2007
Business
U.S. NeuroSurgical Holdings, Inc. primarily operates stereotactic radiosurgery centers through its wholly-owned subsidiaries, specializing in the utilization of gamma knife technology. This technology is a specialized stereotactic radiosurgical device designed to treat brain tumors and other brain malformations non-invasively. The company offers medical services centered on advanced gamma knife radiosurgery aimed at providing precise, minimally invasive treatment options for neurological conditions. Founded in 1993, U.S. NeuroSurgical Holdings is headquartered in Rockville, Maryland, and operates within the healthcare sector, specifically under medical care facilities. In terms of recent developments, the company changed its name to Elite Health Systems Inc. in September 2024 and has shifted its business focus toward developing Medicare Advantage plans and related healthcare services. Since 2023, the company has faced operational challenges, including a complete revenue collapse and persistent losses, indicating a significant strategic pivot from its traditional radiosurgery center operations. Despite maintaining over $3 million in cash reserves, U.S. NeuroSurgical Holdings has seen no revenue generation since early 2023, with active efforts to possibly reposition through acquisitions or strategic realignments in the healthcare sector. The company also experienced significant share dilution and management changes in the recent period. The company's operational history is grounded in neurosurgical treatment technologies, particularly gamma knife radiosurgery, but its latest major strategic changes involve transitioning into Medicare Advantage healthcare service provision under the new brand Elite Health Systems Inc. Geographic operations primarily span the United States, with headquarters in Rockville, Maryland. The company’s enduring challenges and strategic shift illustrate its attempt to move from specialty radiosurgery services toward broader healthcare plan offerings in response to market and internal financial conditions. This pivot represents its most critical recent transformation while it maintains a position in healthcare services with focus on Medicare-related offerings.